0001203311-21-000061.txt : 20210818 0001203311-21-000061.hdr.sgml : 20210818 20210818202835 ACCESSION NUMBER: 0001203311-21-000061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210816 FILED AS OF DATE: 20210818 DATE AS OF CHANGE: 20210818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIU JEAN I CENTRAL INDEX KEY: 0001241357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 211188127 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-08-16 0 0001060736 Seagen Inc. SGEN 0001241357 LIU JEAN I 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 GC/EVP, Leg Affairs Common Stock 2021-08-16 4 S 0 718 154.554 D 63333 D Common Stock 2021-08-16 4 A 0 9246 0.0 A 72579 D Incentive Stock Option (right to buy) 155.87 2021-08-16 4 A 0 642 0.0 A 2031-08-16 Common Stock 642 642 D Non-Qualified Stock Option (right to buy) 155.87 2021-08-16 4 A 0 21915 0.0 A 2031-08-16 Common Stock 21915 21915 D Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. These shares represent restricted stock units and will be settled in common stock upon vesting. Shares shall vest at a rate of 25% on each anniversary of August 15, 2021 until all shares are fully vested at the end of four years. Options shall vest at a rate of 25% one year from grant date and monthly thereafter until all options are fully vested four years from grant date. By: /s/ Elizabeth Bekiroglu For: Jean I. Liu 2021-08-18 EX-24 2 liu_poa.txt EDGAR SUPPORTING DOCUMENT POWER OF ATTORNEY The undersigned hereby constitutes and appoints Todd A. Simpson and Elizabeth Bekiroglu each of them, his or her true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned?s capacity as an officer, director, and/or person who holds more than 10% of the stock of Seattle Genetics, Inc. (the ?Company?), Forms 3, Forms 4 and Forms 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?), and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Forms 3, Forms 4 or Forms 5 and timely file any such forms with the United States Securities and Exchange Commission and any other authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned, pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his or her discretion. The undersigned hereby grants to each such attorney- in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or his or her substitute or substitutes, shall lawfully do or cause to be done pursuant to this power of attorney. The undersigned acknowledges that the foregoing attorneys-in- fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned?s responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, Forms 4, and Forms 5 with respect to the undersigned?s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the attorneys- in-fact. The undersigned has caused this Power of Attorney to be executed as of this 14th day of May, 2021. /s/ Jean Liu Signature